Agenus (AGEN) operates strictly within the Healthcare sector, specifically categorized under the Biotechnology and Pharmaceutical industry. Its core scientific focus centers on immunology and oncology, specializing in the discovery and development of breakthrough treatments designed to harness the human immune system to combat various forms of cancer and chronic diseases through targeted antibodies and vaccine platforms.